Citations

Clear

367 citation(s) found for "Benson, Al".

Dietary factors and pediatric multiple sclerosis: A case-control study
Pakpoor, Julia, Seminatore, Brandon, Schreiner, Teri , Lotze, Timothy , Belman, Anita , Greenberg, Benjamin , Aaen, Gregory , Tillema, Jan‐Mendelt , McDonald, Jamie, Hart, Janace, Ness, Jayne , Harris, Yolanda, Rubin, Jennifer , Candee, Meghan , Gorman, Mark , Rodriguez, Moses , Mar, Soe , Kahn, Ilana , Rose, John , Roalstad, Shelly, Waltz, Michael , Casper, T. Charles , Graves, Jennifer , Schreiner, Teri , Waldman, Amy , Weinstock‐Guttman, Bianca , Krupp, Lauren , Benson, Leslie , Chitnis, Tanuja , Carmichael, Suzan L. , Waubant, Emmanuelle L. , Rodriguez, Moses , Greenberg, Benjamin M , Rubin, Jennifer P

Mayo Clinic

Multiple Sclerosis Journal | June 13, 2017 | Volume: 24 | Issue: 8 | Pages: 1067-1076

10.1177/1352458517713343 | PMID 28608728 Get It

Background: The role of diet in multiple sclerosis (MS) is largely uncharacterized, particularly as it pertains to pediatric-onset disease. Objective: To determine the association between dietary factors and MS in children. Methods: Pediatric MS patients and controls were recruited from 16 US centers (MS or clinically isolated syndrome onset before age 18, <4 years from symptom onset and at least 2 silent lesions on magnetic resonance imaging). The validated Block Kids Food Screener questionnaire was administered 2011–2016. Chi-squared test compared categorical variables, Kruskal–Wallis test compared continuous variables, and multivariable logistic regression analysis was performed. Results: In total, 312 cases and 456 controls were included (mean ages 15.1 and 14.4 years). In unadjusted analyses, there was no difference in intake of fats, proteins, carbohydrates, sugars, fruits, or vegetables. Dietary iron was lower in cases ( p = 0.04), and cases were more likely to consume below recommended guidelines of iron (77.2% of cases vs 62.9% of controls, p < 0.001). In multivariable analysis, iron consumption below recommended guidelines was associated with MS (odds ratio = 1.80, p < 0.01). Conclusion: Pediatric MS cases may be less likely to consume sufficient iron compared to controls, and this warrants broader study to characterize a temporal relationship. No other significant difference in intake of most dietary factors was found.
Phase III trial of adjuvant immunotherapy with MOAb 17–1A following resection for stage II adenocarcinoma of the colon (CALGB 9581)
Colacchio, Thomas A., Warren, Robert S. , Benson, A. I. B., Goldberg, Richard M. , Hollis, Donna, Niedzwiecki, Donna , Compton, Carolyn C. , Kerr, Darcy A. , Fields, Andrew T. , Mayer, Robert J.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3522-3522

10.1200/jco.2004.22.90140.3522 Get It

Evaluation of a revised indication for determining adult cochlear implant candidacy
Sladen, Douglas P. , Gifford, René H. , Haynes, David S. , Kelsall, David C., Benson, Aaron G., Zwolan, Teresa A. , Gantz, Bruce J. , Gilden, Jan, Westerberg, Brian D. , Gustin, Cindy, Driscoll, Colin L. W., Driscoll, Colin L., Lewis, Kristen, Fu, Qian‐Jie , O’Neil, Lori Ross

Mayo Clinic

The Laryngoscope | February 24, 2017 | Volume: 127 | Issue: 10 | Pages: 2368-2374

10.1002/lary.26513 | PMID 28233910 Get It

ObjectiveTo evaluate the use of monosyllabic word recognition versus sentence recognition to determine candidacy and long‐term benefit for cochlear implantation.Study DesignProspective multi‐center single‐subject design.MethodsA total of 21 adults aged 18 years and older with bilateral moderate to profound sensorineural hearing loss and low monosyllabic word scores received unilateral cochlear implantation. The consonant‐nucleus‐consonant (CNC) word test was the central measure of pre‐ and postoperative performance. Additional speech understanding tests included the Hearing in Noise Test sentences in quiet and AzBio sentences in +5 dB signal‐to‐noise ratio (SNR). Quality of life (QoL) was measured using the Abbreviated Profile of Hearing Aid Benefit and Health Utilities Index.ResultsPerformance on sentence recognition reached the ceiling of the test after only 3 months of implant use. In contrast, none of the participants in this study reached a score of 80% on CNC word recognition, even at the 12‐month postoperative test interval. Measures of QoL related to hearing were also significantly improved following implantation.ConclusionResults of this study demonstrate that monosyllabic words are appropriate for determining preoperative candidate and measuring long‐term postoperative speech recognition performance.Level of Evidence2c. Laryngoscope, 127:2368–2374, 2017
Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal Cancer
Tepper, Joel E. , Niedzwiecki, Donna , Hollis, Donna, Compton, Carolyn C. , Benson, Al B. , Cummings, Bernard, Gunderson, Leonard L., Macdonald, John S., O’Connell, Michael J. , Mayer, Robert J. , Niedzwiecki, Donna

Mayo Clinic

Journal of Clinical Oncology | February 24, 2017 | Volume: 19 | Issue: 1 | Pages: 157-163

10.1200/jco.2001.19.1.157 | PMID 11134208 Get It

PURPOSE: We postulated that the pathologic evaluation of the lymph nodes of surgical specimens from patients with rectal cancer can have a substantial impact on time to relapse and survival. PATIENTS AND METHODS: We analyzed data from 1,664 patients with T3, T4, or node-positive rectal cancer treated in a national intergroup trial of adjuvant therapy with chemotherapy and radiation therapy. Associations between the number of lymph nodes found by the pathologist in the surgical specimen and the time to relapse and survival outcomes were investigated. RESULTS: Patients were divided into groups by nodal status and the corresponding quartiles of numbers of nodes examined. The number of nodes examined was significantly associated with time to relapse and survival among patients who were node-negative. For the first through fourth quartiles, the 5-year relapse rates were 0.37, 0.34, 0.26, and 0.19 (P = .003), and the 5-year survival rates were 0.68, 0.73, 0.72, and 0.82 (P = .02). No significant differences were found by quartiles among patients determined to be node-positive. We propose that observed differences are primarily related to the incorrect determination of nodal status in node-negative patients. Approximately 14 nodes need to be studied to define nodal status accurately. CONCLUSION: These results suggest that the pathologic assessment of lymph nodes in surgical specimens is often inaccurate and that examining greater number of nodes increases the likelihood of proper staging. Some patients who might benefit from adjuvant therapy are misclassified as node-negative due to incomplete sampling of lymph nodes.
High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200
Giantonio, Bruce J. , Catalano, Paul J. , Meropol, Neal J. , Mitchell, Edith P. , Schwartz, Morton A., Benson, Al B. , O’Dwyer, P J , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 2-2

10.1200/jco.2005.23.16_suppl.2 Get It

Long-term update of U.S. GI Intergroup RTOG 98-11 phase III trial for anal carcinoma: Comparison of concurrent chemoradiation with 5FU-mitomycin versus 5FU-cisplatin for disease-free and overall survival.
Gunderson, Leonard L., Winter, Kathryn, Pedersen, Jørgen, Benson, Al B. , Thomas, Charles R., Haddock, Michael G. , Rich, Tyvin A. , Willett, Christopher G. , Ajani, Jaffer A. , Mayer, Robert J.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 29 | Issue: 4_suppl | Pages: 367-367

10.1200/jco.2011.29.4_suppl.367 Get It

367 Background: On initial publication of GI Intergroup RTOG 98-11, concurrent chemoradiation with 5FU+mitomycin (MMC) decreased colostomy failure (CF) vs induction plus concurrent 5FU+cisplatin (CDDP), but did not significantly impact disease free or overall survival (DFS, OS). The intent of the current analysis is to determine the long-term impact of treatment on survival (DFS, OS, colostomy-free [CFS]), CF and relapse (local-regional [LRF], distant [DM]) in this patient group. Methods: Stratification factors included gender, clinical node status, and primary size. DFS/OS were estimated univariately by Kaplan-Meier method and treatment arms compared by log-rank test. Time to relapse/CF were estimated by cumulative incidence method and treatment arms compared by Gray's test. Multivariate analyses were done with Cox proportional hazard models to test for treatment differences, adjusting for stratification factors. Results: Of 682 patients accrued, 649 were analyzable for outcomes. As seen in the table, 5-yr DFS and OS were statistically better for RT+5FU/MMC vs RT+5FU/CDDP (67.7 v 57.6%, p=.0.0045; 78.2 v 70.5%, p=0.021) with trends toward statistical significance for CFS, LRF, and CF (71.8 v 64.9%, p=0.053; 20 v 26.5%, 11.9 v 17.3%, p=0.092 and 0.075). Similar results were seen in multivariate analysis. Conclusions: Concurrent chemoradiation with 5FU-MMC has a statistically significant impact on DFS and OS vs induction + concurrent 5FU-CDDP and borderline significance for CFS, CF and LRF. Therefore, RT+5FU/MMC remains the preferred standard of care. Potential strategies to improve outcomes include treatment intensification and individualized molecular-based treatment. Supported by RTOG grant U10 CA21661 and CCOP grant U10 CA37422 from the National Cancer Institute (NCI). [Table: see text] No significant financial relationships to disclose.
Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial
Dyck, Peter J., Dyck, Peter J., Kincaid, John C., Dyck, P. James B. , Chaudhry, Vinay , Goyal, Namita , Alves, Christina , Salhi, Hayet, Wiesman, Janice F. , Labeyrie, Céline , Robinson‐Papp, Jessica , Cardoso, Márcio , Laurá, Matilde , Ruzhansky, Katherine , Cortese, Andrea , Brannagan, Thomas H., Khoury, Julie, Khella, Sami, Ferreira, João , Wang, Annabel K., Pinto, Marcus Vinícius , Ayache, Samar S. , Benson, Merrill D., Coelho, Teresa , Polydefkis, Michael , Gorevic, Peter D., Planté‐Bordeneuve, Violaine , Whelan, Carol , Merlini, Giampaolo , Drachman, Brian, Conceição, Isabel , Klein, Christopher J. , Ackermann, Elizabeth J., Hughes, Steven G. , Mauermann, Michelle L. , Bergemann, R , Lodermeier, Karen A., Davies, Jenny L., Carter, Rickey E. , Litchy, William J. , Dyck, Peter J., Dyck, Peter J., Waddington‐Cruz, Márcia , Berk, John L. , Adams, David , Heitner, Stephen B. , Gertz, Morie A. , Merlini, Giampaolo , Pinto, Marcus V , Klein, Christopher J , Brannagan, T H , Carter, Rickey E , Conceição, Isabel , Mauermann, Michelle L

Mayo Clinic

Muscle & Nerve | January 7, 2017 | Volume: 56 | Issue: 5 | Pages: 901-911

10.1002/mus.25563 | PMID 28063170 Get It

ABSTRACTIntroductionPolyneuropathy signs (Neuropathy Impairment Score, NIS), neurophysiologic tests (m+7Ionis), disability, and health scores were assessed in baseline evaluations of 100 patients entered into an oligonucleotide familial amyloidotic polyneuropathy (FAP) trial.MethodsWe assessed: (1) Proficiency of grading neurologic signs and correlation with neurophysiologic tests, and (2) clinometric performance of modified NIS+7 neurophysiologic tests (mNIS+7Ionis) and its subscores and correlation with disability and health scores.ResultsThe mNIS+7Ionis sensitively detected, characterized, and broadly scaled diverse polyneuropathy impairments. Polyneuropathy signs (NIS and subscores) correlated with neurophysiology tests, disability, and health scores. Smart Somatotopic Quantitative Sensation Testing of heat as pain 5 provided a needed measure of small fiber involvement not adequately assessed by other tests.ConclusionsSpecially trained neurologists accurately assessed neuropathy signs as compared to referenced neurophysiologic tests. The score, mNIS+7Ionis, broadly detected, characterized, and scaled polyneuropathy abnormality in FAP, which correlated with disability and health scores. Muscle Nerve 56: 901–911, 2017
Distinct effects of obesity and puberty on risk and age at onset of pediatric MS
Belman, Anita , Olsen, Cody S., Misra, Madhusmita , Aaen, Gregory , Candee, Meghan , Gorman, Mark , Greenberg, Benjamin , Lotze, Timothy , Mar, Soe , Ness, Jayne , Rose, John , Rubin, Jennifer , Schreiner, Teri , Tillema, Jan Mendelt, Rodriguez, Moses , Casper, Charlie, Tillema, Jan, Chitnis, Tanuja , Graves, Jennifer , Weinstock‐Guttman, Bianca , Benson, Leslie , Krupp, Lauren , Schreiner, Teri , Waldman, Amy , Waubant, Emmanuelle L. , Rodriguez, Moses , Greenberg, Benjamin M , Rubin, Jennifer P

Mayo Clinic

Annals of Clinical and Translational Neurology | November 5, 2016 | Volume: 3 | Issue: 12 | Pages: 897-907

10.1002/acn3.365 | PMID 28097202 Get It

AbstractObjectiveThe aim of this study was to examine the relative contributions of body mass index (BMI) and pubertal measures for risk and age of onset of pediatric MS.MethodsCase–control study of 254 (63% female) MS cases (onset<18 years of age) and 420 (49% female) controls conducted at 14 U.S. Pediatric MS Centers. Sex‐ and age‐stratified BMI percentiles were calculated using CDC growth charts from height and weight measured at enrollment for controls, and within 1 year of onset for MS cases. Sex‐stratified associations between MS risk and age at symptom onset with both BMI and pubertal factors were estimated controlling for race and ethnicity.ResultsOnly 11% of girls and 15% of boys were prepubertal (Tanner stage I) at MS onset. 80% of girls had onset of MS after menarche. BMI percentiles were higher in MS cases versus controls (girls: P < 0.001; boys: P = 0.018). BMI was associated with odds of MS in multivariate models in postpubertal girls (OR = 1.60, 95% confidence interval [CI]: 1.12, 2.27, P = 0.009) and boys (OR = 1.43, 95% CI: 1.08, 1.88, P = 0.011). In girls with MS onset after menarche, higher BMI was associated with younger age at first symptoms (P = 0.031). Younger menarche was associated with stronger effects of BMI through mediation and interaction analysis. In pubertal/postpubertal boys, 89% of whom were obese/overweight, earlier sexual maturity was associated with earlier onset of MS (P < 0.001).InterpretationHigher BMI in early adolescence is a risk factor for MS in girls and boys. Earlier age at sexual maturity contributes to earlier age at MS onset, particularly in association with obesity.
Characteristics of Children and Adolescents With Multiple Sclerosis
Belman, Anita , Krupp, Lauren , Olsen, Cody S., Rose, John , Aaen, Greg, Gorman, Mark , Harris, Yolander, Lotze, Tim, Ness, Jayne , Rodriguez, Moses , Tillema, Jan‐Mendelt , Casper, T. Charles , Krupp, Lauren , Aaen, Gregory , Benson, Lina , Chitnis, Tanuja , Graves, Jennifer , Waubant, Emmanuelle L. , Weinstock‐Guttman, Bianca , Rodriguez, Moses

Mayo Clinic

Pediatrics | June 29, 2016 | Volume: 138 | Issue: 1 | Pages: No page available

10.1542/peds.2016-0120 | PMID 27358474 Get It

OBJECTIVES: To describe the demographic and clinical characteristics of pediatric multiple sclerosis (MS) in the United States. METHODS: This prospective observational study included children and adolescents with MS. Cases were evaluated across 9 geographically diverse sites as part of the US Network of Pediatric MS Centers. RESULTS: A total of 490 children and adolescents (324 girls, 166 boys) were enrolled; 28% developed symptoms before 12 years of age. The proportion of girls increased with age from 58% (&lt;12 years) to 70% (≥12 years). Race and ethnicity as self-identified were: white, 67%; African American, 21%; and non-Hispanic, 70%. Most (94%) of the cases were born in the United States, and 39% had 1 or both foreign-born parents. Fifty-five percent of cases had a monofocal presentation; 31% had a prodrome (most frequently infectious), most often among those aged &lt;12 years (P &lt; .001). Children aged &lt;12 years presented more commonly with encephalopathy and coordination problems (P &lt; .001). Sensory symptoms were more frequently reported by older children (ie, those aged ≥12 years) (P &lt; .001); 78% of girls had MS onset postmenarche. The initial Expanded Disability Status Scale score for the group was &lt;3.0, and the annualized relapse rate was 0.647 for the first 2 years. Interval from symptom onset to diagnosis and from diagnosis to initiation of disease-modifying therapy was longer among those &lt;12 years of age. CONCLUSIONS: Pediatric MS in the United States is characterized by racial and ethnic diversity, a high proportion of children with foreign-born parents, and differences in clinical features and timing of treatment among those &lt;12 years of age compared with older children.